NTRA.NASDAQNatera, INC

Form 4: Natera Director Sells $11M in Stock After RSU Grant

Sentiment:

Insider Transaction Report


Natera Director Herm Rosenman sold approximately $11 million worth of common stock in multiple transactions on December 12, 2025, following the acquisition of 132 restricted stock units on October 31, 2025.

Summary

  • Herm Rosenman, a Director of Natera, Inc. (NTRA), reported changes in his beneficial ownership of common stock.
  • On October 31, 2025, Rosenman acquired 132 shares of Natera Common Stock through Restricted Stock Units (RSUs) in lieu of quarterly retainer fees of $23,750 for his board service. These RSUs were fully vested upon issuance.
  • On December 12, 2025, Rosenman disposed of a total of 48,419 shares of Natera Common Stock across four separate transactions.
  • The sales occurred at weighted average prices ranging from $226.6174 to $229.095 per share.
  • Following these transactions, Rosenman's direct beneficial ownership of Natera Common Stock decreased to 20,342 shares.
  • The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing reports a director's sale of shares, which is a neutral event in itself, especially given it was pre-planned under a 10b5-1 plan. While a reduction in insider ownership can be seen negatively, it's a common part of executive compensation and personal financial management.

Positives

  • The acquisition of 132 shares via RSUs demonstrates continued compensation for board service, aligning director interests with shareholders.
  • The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-planned sales rather than a reaction to immediate market conditions.

Negatives

  • A significant sale of 48,419 shares by a director, totaling approximately $11 million, reduces insider ownership.
  • The reduction in beneficial ownership from 68,761 shares to 20,342 shares represents a substantial decrease in the director's direct stake.

Industry Context

This Form 4 filing reflects routine insider transaction disclosures for a director of a publicly traded biotechnology company. Such sales, especially when pre-planned under a 10b5-1 plan, are common for executive compensation and personal financial management and do not necessarily indicate a change in company fundamentals or industry trends.

Related Party Transactions

  • The acquisition of 132 Restricted Stock Units (RSUs) by Director Herm Rosenman in lieu of quarterly retainer fees of $23,750 for board service can be considered a related party transaction as it involves compensation from the issuer to a director.

Stakeholder Impact

  • Shareholders: A reduction in director ownership could be perceived negatively by some investors, though the 10b5-1 plan mitigates concerns about opportunistic selling. The RSU grant aligns director interests with long-term shareholder value.

Key Dates

DateDescription
10/31/2025Acquisition of 132 shares of Common Stock via Restricted Stock Units (RSUs) by Director Herm Rosenman.
12/12/2025Sale of 48,419 shares of Common Stock by Director Herm Rosenman in multiple transactions.
12/16/2025Date of filing signature by Attorney-in-Fact Vincent Fontanilla.

Recommendation

hold

The filing details a pre-planned sale of shares by a director, which is a routine event for insider compensation and personal financial management. While it reduces insider ownership, the 10b5-1 plan suggests the sale is not based on new, material non-public information. Therefore, this specific filing alone does not provide a strong basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate, pending further fundamental analysis of the company.

Keywords

Natera, NTRA, Insider Trading, Form 4, Stock Sale, Director, Herm Rosenman, Restricted Stock Units, RSU, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.